A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 Incidence.
Lorenz SchubertRobert StrasslHeinz BurgmannGabriella DvorakMatthias KarerMichael KundiManuel KussmannHeimo LaglerFelix LötschChristopher MilacekMarkus ObermuellerZoe OesterreicherChristoph SteiningerKarin StiasnyFlorian ThalhammerLudwig TrabyZoltan VassMatthias Gerhard VossenLukas WeseslindtnerStefan WinklerSelma TobudicPublished in: International journal of environmental research and public health (2021)
Personal protective equipment and adherence to disinfection protocols are essential to prevent nosocomial severe acute respiratory syndrome coronavirus (SARS-CoV-2) transmission. Here, we evaluated infection control measures in a prospective longitudinal single-center study at the Vienna General Hospital, the biggest tertiary care center in Austria, with a structurally planned low SARS-CoV-2 exposure. SARS-CoV-2-specific antibodies were assessed by Abbott ARCHITECT chemiluminescent assay (CLIA) in 599 health care workers (HCWs) at the start of the SARS-CoV-2 epidemic in early April and two months later. Neutralization assay confirmed CLIA-positive samples. A structured questionnaire was completed at both visits assessing demographic parameters, family situation, travel history, occupational coronavirus disease 2019 (COVID-19) exposure, and personal protective equipment handling. At the first visit, 6 of 599 participants (1%) tested positive for SARS-CoV-2-specific antibodies. The seroprevalence increased to 1.5% (8/553) at the second visit and did not differ depending on the working environment. Unprotected SARS-CoV-2 exposure (p = 0.003), positively tested family members (p = 0.04), and travel history (p = 0.09) were more frequently reported by positively tested HCWs. Odds for COVID-19 related symptoms were highest for congestion or runny nose (p = 0.002) and altered taste or smell (p < 0.001). In conclusion, prevention strategies proved feasible in reducing the risk of transmission of SARS-CoV-2 from patients and among HCWs in a low incidence hospital, not exceeding the one described in the general population.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- tertiary care
- end stage renal disease
- healthcare
- high throughput
- metabolic syndrome
- physical activity
- chronic kidney disease
- adipose tissue
- type diabetes
- newly diagnosed
- emergency department
- escherichia coli
- skeletal muscle
- ejection fraction
- patient reported outcomes
- drug resistant
- cystic fibrosis
- prognostic factors
- acute care
- klebsiella pneumoniae
- infectious diseases